Medical News Today: What to know about azithromycin
Azithromycin is an antibiotic drug. It can help treat a range of bacterial infections that affect the lungs, sinuses, skin, and other parts of the body. Learn about its uses, risks, side effects, and how to use it here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 12, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news
Suprax (cefixime) vs. azithromycin
Title: Suprax (cefixime) vs. azithromycinCategory: MedicationsCreated: 7/9/2019 12:00:00 AMLast Editorial Review: 7/9/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - July 9, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms
The U.S. Food and Drug Administration (FDA) is warning the public that azithromycin (Zithromax or Zmax) can cause abnormal changes in the electrical activity of the heart that may lead to a potentially fatal irregular heart rhythm. Patients at particular risk for developing this condition include those with known risk factors such as existing QT interval prolongation, low blood levels of potassium or magnesium, a slower than normal heart rate, or use of certain drugs used to treat abnormal heart rhythms, or arrhythmias. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - June 22, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news
What Causes Facial Nerve Palsy?
Discussion
Facial nerve palsy has been known for centuries, but in 1821 unilateral facial nerve paralysis was described by Sir Charles Bell. Bell’s palsy (BP) is a unilateral, acute facial paralysis that is clinically diagnosed after other etiologies have been excluded by appropriate history, physical examination and/or laboratory testing or imaging. Symptoms include abnormal movement of facial nerve. It can be associated with changes in facial sensation, hearing, taste or excessive tearing. The right and left sides are equally affected but bilateral BP is rare (0.3%). Paralysis can be complete or incomplete at prese...
Source: PediatricEducation.org - June 3, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
Medical News Today: What happens when you mix azithromycin and alcohol?
Azithromycin is a drug that has uses in treating bacterial infections. Mixing with alcohol may cause issues including nausea, headache, and dizziness or other problems. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - May 28, 2019 Category: Consumer Health News Tags: Alcohol / Addiction / Illegal Drugs Source Type: news
UIC to lead national COPD clinical trial
(University of Illinois at Chicago) The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs -- azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication -- is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2019 Category: International Medicine & Public Health Source Type: news
Doxycycline vs. Azithromycin
Title: Doxycycline vs. AzithromycinCategory: MedicationsCreated: 5/7/2019 12:00:00 AMLast Editorial Review: 5/7/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 7, 2019 Category: Drugs & Pharmacology Source Type: news
New drug combination could be effective for treatment-resistant gonorrhoea
Gentamicin with azithromycin was found to be almost as effective as the currently used first-line treatment for gonorrhoea Related items fromOnMedica Promise to end new HIV transmissions in England by 2030 Use condoms to cut spread of drug-resistant gonorrhoea HPV programme linked to dramatic fall in cervical disease Uptake of PrEP coincides with less condom use Gonorrhoea becoming difficult or impossible to treat, warns WHO (Source: OnMedica Latest News)
Source: OnMedica Latest News - May 6, 2019 Category: UK Health Source Type: news
Azithromycin May Reduce Treatment Failure for COPD Exacerbations Azithromycin May Reduce Treatment Failure for COPD Exacerbations
An extended course of low-dose azithromycin may significantly reduce treatment failure in patients hospitalized for acute exacerbation of chronic obstructive pulmonary disease (COPD), new data suggest.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 6, 2019 Category: Allergy & Immunology Tags: Pulmonary Medicine News Source Type: news
Azithromycin May Reduce Treatment Failure for COPD
Exacerbations (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 6, 2019 Category: General Medicine Source Type: news
Impact of Azithromycin Studied in Acute Exacerbation of COPD
Azithromycin leads to significant drops in treatment intensification and step - up in hospital care (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 3, 2019 Category: Respiratory Medicine Tags: Internal Medicine, Critical Care, Pharmacy, Pulmonology, Journal, Source Type: news
Impact of Azithromycin Studied in Acute Exacerbation of COPD
FRIDAY, May 3, 2019 -- Three months of azithromycin did not significantly reduce treatment failure (TF) among patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (AECOPD), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 3, 2019 Category: Pharmaceuticals Source Type: news
Azithromycin appears to reduce treatment failure in severe, acute COPD exacerbations
(American Thoracic Society) The antibiotic azithromycin may reduce treatment failure in patients hospitalized for an acute exacerbation of chronic obstructive pulmonary disease (COPD), according to a randomized, controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 3, 2019 Category: International Medicine & Public Health Source Type: news
Drug combination could be effective for treatment-resistant gonorrhea
(National Institute for Health Research) Scientists comparing treatments for gonorrhea have identified a drug combination that could be an effective back-up for patients not responding to current therapy. The research team, from University Hospitals Birmingham, found that a treatment of the antibiotic gentamicin with azithromycin worked almost as well as the currently used ceftriaxone for genital gonorrhea. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 2, 2019 Category: Infectious Diseases Source Type: news
Gonorrhoea: Drug resistance compromises recommended treatment in Europe
(European Centre for Disease Prevention and Control (ECDC)) Gonorrhoea is the second most commonly notified sexually transmitted infection across the EU/EEA countries with almost 500 000 reported cases between 2007 and 2016. The infection is treatable but Neisseria gonorrhoeae keep showing high levels of azithromycin resistance according to latest results of the European Gonococcal Antimicrobial Surveillance Programme. This antibiotic agent is part of the currently recommended therapy regimen for gonorrhoea and observed resistance patterns threaten its effectiveness. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - February 28, 2019 Category: Infectious Diseases Source Type: news
